Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
8
×
cancer
8
×
drugs
8
×
national blog main
national top stories
8
×
texas blog main
texas top stories
boston top stories
detroit blog main
detroit top stories
life sciences
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
indiana blog main
indiana top stories
national
biotech
fda
startups
roche
abbvie
deals
gene therapy
investing
pfizer
agios pharmaceuticals
american society of hematology
What
bio
drug
fda
medical
roundup
american
annual
approved
ash
big
blood
companies
conference
diego
disease
gathering
largest
new
san
society
week
admits
ago
ahead
alzheimer’s
announced
asco
assessed
attention
biotech
biotechs
borne
branded
cancer
cancers
center
center’s
choices
classes
combinator
Language
unset
Current search:
drugs
×
cancer
×
" national top stories "
×
" boston blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More